Cygnus Health Care Specialities Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 106.49%
(FY 2023)
- Profit 28.48%
(FY 2023)
- Ebitda 29.24%
(FY 2023)
- Net Worth -229.96%
(FY 2023)
- Total Assets 23.26%
(FY 2023)
About Cygnus Health Care Specialities
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ujwala Iyer and Ganesan Iyer serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC153761
- Company No.
153761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cygnus Health Care Specialities Private Limited offer?
Cygnus Health Care Specialities Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Sexual Wellness Products, Fertility Enhancer, Common Disease Medicines, Eye Drops, Thyroxine Sodium Tablets, Anti Cancer Injection, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Cygnus Health Care Specialities?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujwala Iyer  | Director | 01-Apr-2007 | Current |
| Ganesan Iyer | Director | 03-Jun-2005 | Current |
Financial Performance of Cygnus Health Care Specialities.
Cygnus Health Care Specialities Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 106.49% increase. The company also saw a substantial improvement in profitability, with a 28.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 229.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cygnus Health Care Specialities?
In 2023, Cygnus Health Care Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cygnus Health Care Specialities?
Unlock and access historical data on people associated with Cygnus Health Care Specialities, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cygnus Health Care Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cygnus Health Care Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
